Schedule 13G ownership disclosure

PIERIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 720795202

Event date: 2024-07-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
138,641
Percent of class
10.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-084642
Form type
SC 13G
Filer
ADAR1 Capital Management, LLC
CIK
CIK 1940272
Filed
Aug 01, 2024
Reporting period
Jul 24, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub